WAYNE, N.J. and EMERYVILLE, Calif., Oct. 23 (HSMN NewsFeed) — Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced the companies have begun enrolling patients in an international Phase 3 trial to evaluate…
Biopharmaceuticals, Oncology
Onyx Pharmaceuticals, Bayer HealthCare Pharmaceuticals, Nexavar, sorafenib

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Patients With Non-Responsive Thyroid Cancer”
Leave a Comment